12.17.10
Patheon 4Q10
4Q Revenues: $177.7 million (+1%)
4Q Loss: $1.8 million (loss of $4.6 million YTD09)
YTD Revenues: $671.2 million (+3%)
YTD Loss: $5.0 million (loss of $6.8 million YTD09)
Comments: Commercial manufacturing revenues were flat at $144.8 million in the quarter. North American commercial revenues decreased $5.0 million (-7%), while European commercial revenues increased $5.6 million (+8%). Pharmaceutical Development Services revenues for the quarter were up 3% to $32.9 million.
4Q Revenues: $177.7 million (+1%)
4Q Loss: $1.8 million (loss of $4.6 million YTD09)
YTD Revenues: $671.2 million (+3%)
YTD Loss: $5.0 million (loss of $6.8 million YTD09)
Comments: Commercial manufacturing revenues were flat at $144.8 million in the quarter. North American commercial revenues decreased $5.0 million (-7%), while European commercial revenues increased $5.6 million (+8%). Pharmaceutical Development Services revenues for the quarter were up 3% to $32.9 million.
